Karl Gisslander
1 – 10 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Ontology-based integration and querying of heterogeneous rare disease data sources — POLVAS perspective
(
- Contribution to journal › Article
- 2024
-
Mark
Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden
(
- Contribution to journal › Article
-
Mark
Mortality Rate by Diagnosis in ANCA-Associated Vasculitis Across FAIRVASC Registries
2024) p.187-187(
- Contribution to conference › Abstract
-
Mark
Drug exposure and subsequent diagnosis with ANCA-associated vasculitis – A population-based case- control study
2024) p.191-191(
- Contribution to conference › Abstract
-
Mark
Temporal clustering of ANCA-associated vasculitis occurrence
2024) p.471-471(
- Contribution to conference › Abstract
-
Mark
Data-driven subclassification of ANCA-associated vasculitis : model-based clustering of a federated international cohort
(
- Contribution to journal › Article
-
Mark
Disease Phenotypes and Prediction of Outcome in ANCA-associated vasculitis
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Epidemiology and clinical characteristics of biopsy-confirmed adult-onset IgA vasculitis in southern Sweden
(
- Contribution to journal › Article
- 2023
-
Mark
Can active sun exposure decrease the risk of giant cell arteritis and polymyalgia rheumatica in women?
(
- Contribution to journal › Article
-
Mark
Overcoming challenges in rare disease registry integration using the semantic web - a clinical research perspective
(
- Contribution to journal › Letter